Testing effectiveness (Phase 2)Study completedNCT00120705What this trial is testingTreatment for Anemic Subjects With Non-Myeloid Malignancies Receiving ChemotherapyWho this might be right forNeoplasmsAnemia Amgen 204
Large-scale testing (Phase 3)Study completedNCT00003436What this trial is testingCombination Chemotherapy With or Without Bone Marrow Transplantation in Treating Children With Acute Myeloid LeukemiaWho this might be right forLeukemiaMyelodysplastic Syndromes Medical Research Council 2,000
Not applicableActive Not RecruitingNCT07821229What this trial is testingCombination of Mitomycin and Carboplatin in Neoadjuvant Therapy in BRCA-associated Triple-negative Locally Advanced Breast CancerWho this might be right forBreast Cancer (Early Breast Cancer)BRCA 1 Gene MutationBRCA 2 Gene Mutation N.N. Petrov National Medical Research Center of Oncology 30
Not applicableStudy completedNCT05972577What this trial is testingGeriatric Optimization Plan to Improve Survival in Older Adult Allogeneic Hematopoietic Cell Transplant Candidates, OTIS StudyWho this might be right forAcute Lymphoblastic LeukemiaAcute Myeloid LeukemiaAplastic Anemia+9 more Ohio State University Comprehensive Cancer Center 30
Not applicableUnknownNCT02338479What this trial is testingNatural History and Biology of Long-Term Late Effects Following Hematopoietic Cell Transplant for Childhood Hematologic MalignanciesWho this might be right forAcute Lymphoblastic Leukemia/LymphomaMyelodysplasiaAcute Myelogenous Leukemia+2 more Center for International Blood and Marrow Transplant Research 340
Testing effectiveness (Phase 2)Study completedNCT00540696What this trial is testingStudy to Develop a Screening Tool for Functional Capacity in Anemic Subjects With Nonmyeloid Malignancies Receiving Chemotherapy and Darbepoetin AlfaWho this might be right forAnemiaNon-Myeloid Malignancies Amgen 300
Large-scale testing (Phase 3)Ended earlyNCT00350090What this trial is testingAssess the Response Rate of PROCRIT (Epoetin Alfa) Given at a Dose of 40,000 Units Once a Week to Cancer Patients With Anemia Who Are Not Receiving Chemotherapy.Who this might be right forAnemiaNeoplasms Ortho Biotech Products, L.P. 98
Large-scale testing (Phase 3)Ended earlyNCT00189371What this trial is testingReinduction Chemotherapy Containing Carboplatin and Paclitaxel With or Without Epoetin Alpha in Recurrent Platinum Sensitive Ovarian Cancer, Cancer of the Fallopian Tube or PeritoneumWho this might be right forEpithelial Ovarian Cancer, Fallopian Tube or PeritoneumPlatinum Sensitve RelapseAnemia AGO Study Group 300
Testing effectiveness (Phase 2)Looking for participantsNCT04954599What this trial is testingPhase 1/2 Clinical Trial of CP-506 (HAP) in Monotherapy or With Carboplatin or ICIWho this might be right forUnspecified Adult Solid Tumor, Protocol Specific Maastricht University Medical Center 126
Early research (Phase 1)Study completedNCT00004871What this trial is testingAzacitidine Plus Phenylbutyrate in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic SyndromeWho this might be right forLeukemiaMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative Diseases Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Not applicableEnded earlyNCT00255684What this trial is testingFludarabine, Cyclophosphamide, and Total-Body Irradiation Followed by Cyclosporine and Mycophenolate Mofetil in Treating Patients Who Are Undergoing a Donor Umbilical Cord Blood Transplant for Hematologic CancerWho this might be right forChronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+4 more University of Rochester 16
Testing effectiveness (Phase 2)Ended earlyNCT00719849What this trial is testingDonor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematological Cancer or Other DiseaseWho this might be right forLeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+2 more Fred Hutchinson Cancer Center 13
Large-scale testing (Phase 3)Study completedNCT00364455What this trial is testingImpact of Erythropoietin Treatment Versus Placebo on Quality-of-life in Patients With Advanced Prostate Cancer.Who this might be right forProstateCarcinoma Janssen-Ortho Inc., Canada 56
Early research (Phase 1)Looking for participantsNCT07379125What this trial is testingTherapeutic RSK1 Targeting in MyelofibrosisWho this might be right forMyelofibrosis Washington University School of Medicine 18
Large-scale testing (Phase 3)UnknownNCT03728543What this trial is testingThe Efficacy and Safety of Sugammadex in Children 0-2 Years OldWho this might be right forAnesthesiaPediatric CancerPediatric Tumor+3 more Federal Research Institute of Pediatric Hematology, Oncology and Immunology 62
Testing effectiveness (Phase 2)Study completedNCT05963334What this trial is testingComparison of Weekly Versus Every Three Weeks of Carboplatin Plus Paclitaxel in Patients With Advanced Epithelial Ovarian CancerWho this might be right forAdvanced Epithelial Ovarian Cancer Cairo University 49
Not applicableEnded earlyNCT01962636What this trial is testingUmbilical Cord Blood Transplantation Using a Myeloablative Preparative Regimen for Hematological DiseasesWho this might be right forAcute Myeloid Leukemia (AML)Acute Lymphocytic Leukemia (ALL)Chronic Myelogenous Leukemia+15 more Masonic Cancer Center, University of Minnesota 200
Early research (Phase 1)Study completedNCT00003693What this trial is testingDolastatin 10 in Treating Patients With Refractory or Relapsed Acute Leukemia, Myelodysplastic Syndrome, or Chronic Myelogenous LeukemiaWho this might be right forLeukemiaMyelodysplastic Syndromes M.D. Anderson Cancer Center 30
Early research (Phase 1)Ended earlyNCT02231853What this trial is testingPhase I/II Trial of Early Infusion of Rapidly-generated Multivirus Specific T Cells (MVST) to Prevent Post Transplant Viral InfectionsWho this might be right forChronic Lymphocytic LeukemiaCML (Chronic Myelogenous Leukemia)MDS (Myelodysplastic Syndrome)+2 more National Heart, Lung, and Blood Institute (NHLBI) 12
Not applicableUnknownNCT00509509What this trial is testingHigh Risk Breast Cancer Screening ProgramWho this might be right forBreast Cancer Organisation for Oncology and Translational Research